320 related articles for article (PubMed ID: 6274959)
1. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
Tosato G; Magrath IT; Blaese RM
J Immunol; 1982 Feb; 128(2):575-9. PubMed ID: 6274959
[TBL] [Abstract][Full Text] [Related]
2. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.
Tosato G; Magrath I; Koski I; Dooley N; Blaese M
N Engl J Med; 1979 Nov; 301(21):1133-7. PubMed ID: 226884
[TBL] [Abstract][Full Text] [Related]
3. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
Tosato G; Straus S; Henle W; Pike SE; Blaese RM
J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
Tsokos GC; Magrath IT; Balow JE
J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulatory functions of cultured human T lymphocytes.
Uchiyama T; Broder S; Bonnard GD; Waldmann TA
Trans Assoc Am Physicians; 1980; 93():251-62. PubMed ID: 6264658
[TBL] [Abstract][Full Text] [Related]
6. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.
Wang F; Blaese RM; Zoon KC; Tosato G
J Clin Invest; 1987 Jan; 79(1):7-14. PubMed ID: 3025263
[TBL] [Abstract][Full Text] [Related]
7. B cell differentiation and immunoregulatory T cell function in human cord blood lymphocytes.
Tosato G; Magrath IT; Koski IR; Dooley NJ; Blaese RM
J Clin Invest; 1980 Aug; 66(2):383-8. PubMed ID: 6249850
[TBL] [Abstract][Full Text] [Related]
8. Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV).
Gergely P; Ernberg I; Klein G; Steinitz M
Clin Exp Immunol; 1977 Dec; 30(3):347-53. PubMed ID: 203426
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
Konttinen YT; Bluestein HG; Zvaifler NJ
J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
[TBL] [Abstract][Full Text] [Related]
10. Immunoregulatory human T lymphocytes triggered as a consequence of viral infection: clonal analysis of helper, suppressor inducer and suppressor effector cell populations.
Meuer SC; Cooper DA; Hodgdon JC; Hussey RE; Morimoto C; Schlossman SF; Reinherz EL
J Immunol; 1983 Sep; 131(3):1167-72. PubMed ID: 6309959
[TBL] [Abstract][Full Text] [Related]
11. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
Kuwano K; Arai S; Munakata T; Tomita Y; Yoshitake Y; Kumagai K
J Immunol; 1986 Sep; 137(5):1462-8. PubMed ID: 3018077
[TBL] [Abstract][Full Text] [Related]
12. Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation method.
Tanaka Y; Sugamura K; Hinuma Y; Sato H; Okochi K
J Immunol; 1980 Oct; 125(4):1426-31. PubMed ID: 6157733
[TBL] [Abstract][Full Text] [Related]
13. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
Klein E; Ernberg I; Masucci MG; Szigeti R; Wu YT; Masucci G; Svedmyr E
Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
[TBL] [Abstract][Full Text] [Related]
14. Defective EBV-specific suppressor T-cell function in rheumatoid arthritis.
Tosato G; Steinberg AD; Blaese RM
N Engl J Med; 1981 Nov; 305(21):1238-43. PubMed ID: 6270556
[TBL] [Abstract][Full Text] [Related]
15. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
Nemerow GR; McNaughton ME; Cooper NR
J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
[TBL] [Abstract][Full Text] [Related]
16. Human B lymphocytes activated by Epstein-Barr virus (EBV) or by mitogens suppress mitogen-induced immunoglobulin production.
Tsukuda K; Berczi I; Klein G
J Immunol; 1981 May; 126(5):1810-3. PubMed ID: 6260858
[TBL] [Abstract][Full Text] [Related]
17. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
Tosato G; Blaese RM; Yarchoan R
J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369
[TBL] [Abstract][Full Text] [Related]
18. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
Thorley-Lawson DA
J Immunol; 1980 Feb; 124(2):745-51. PubMed ID: 6243331
[TBL] [Abstract][Full Text] [Related]
19. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
[TBL] [Abstract][Full Text] [Related]
20. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.
Birx DL; Redfield RR; Tosato G
N Engl J Med; 1986 Apr; 314(14):874-9. PubMed ID: 3005862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]